미국의 이미징 서비스 시장 규모, 점유율과 동향 분석 보고서 : 기술별, 용도별, 최종 용도별, 부문 예측(2026-2033년)

U.S. Imaging Services Market Summary

The U.S. imaging services market size was estimated at USD 104.25 billion in 2025 and is expected to reach USD 121.32 billion by 2033, growing at a CAGR of 1.9% from 2026 to 2033. The major factors attributed to the growth include the increasing prevalence of cancer and cardiac disorders, coupled with growing awareness about medical imaging technology.

In addition, developing various technologies for enhancing medical imaging services is anticipated to boost market growth during the forecast period. Medical imaging is the preferred diagnostic technique, providing vital information with speed, safety, and accuracy. Imaging services involve different imaging modalities such as X-ray, ultrasound, nuclear medicine scans, MRI, and CT scans, which are non-invasive techniques that can be used to diagnose various diseases easily. In addition, these imaging services help in the early diagnosis of the disease, which leads to positive treatment outcomes. The development of various technologies for enhancing medical imaging services is anticipated to boost market growth in the coming years. Furthermore, the rapidly increasing aging population and high cancer incidence are factors expected to drive market growth. Growing funding to support ongoing research activities and rising private-public initiatives related to medical imaging are factors likely to propel overall market growth.

Medical imaging helps with the early and accurate diagnosis of diseases, which helps in providing effective disease treatment. Therefore, to control the growing disease burden, a large number of medical professionals are using medical imaging devices in imaging services before performing surgeries. The growing prevalence of cancer and cardiovascular diseases is expected to drive the need for medical imaging services. According to the National Cancer Institute, an estimated 2,041,910 new cases of cancer will be diagnosed in the U.S. and 618,120 deaths from the disease in 2025. This indicates a major rise from a total of 611,720 cancer deaths projected for 2024.

In interventional radiology, healthcare professionals use medical imaging systems to guide minimally invasive surgical procedures that treat, diagnose, and cure several conditions. Imaging modalities include CT, fluoroscopy, ultrasound, and MRI. Minimally invasive surgeries offer numerous benefits, such as faster recovery time, smaller incisions, reduced scarring and pain, increased accuracy, and shorter hospital stays compared to open surgery techniques, which are expected to fuel the industry.

U.S. Imaging Services Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. imaging services market report based on technology, application, and end use:

• Technology Outlook (Revenue, USD Million, 2021 - 2033)
• Mobile & Interim Imaging Services
  • Magnetic Resonance Imaging (MRI)
  • Positron Emission Tomography - Computed Tomography (PET/CT)
  • Catheterization & Angiography (Cath/Angio)
  • Nuclear Medicine
  • Bone Density (DEXA Scan)
  • Ultrasound
  • Mammography (2D & 3D)
• Fixed Radiology Services
  • MRI
  • Computed Tomography (CT)
  • X-ray
  • Mammography
  • Ultrasound
  • Nuclear Imaging
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Orthopedics
• Gynecology
• Oncology
• Cardiology
• Gastroenterology
• Neurology
• Other Applications
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Diagnostic Imaging Centers
• Mobile Imaging Providers
• Others

Table of Contents

Chapter 1. U.S. Imaging Services Market: Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Technology
  • 1.2.2. Application
  • 1.2.3. End use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. U.S. Imaging Services Market: Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
  • 2.2.1. Technology outlook
  • 2.2.2. Application outlook
  • 2.2.3. End use outlook
• 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Imaging Services Market: Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Industry Value Chain Analysis
  • 3.3.1. Reimbursement framework
• 3.4. Market Dynamics
  • 3.4.1. Market Driver Analysis
  • 3.4.2. Market Restraint Analysis
• 3.5. U.S. Imaging Services Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.5.1.1. Supplier Power
    • 3.5.1.2. Buyer Power
    • 3.5.1.3. Substitution Threat
    • 3.5.1.4. Threat of New Entrants
    • 3.5.1.5. Competitive Rivalry
  • 3.5.2. PESTLE Analysis

Chapter 4. U.S. Imaging Services Market: Technology Estimates & Trend Analysis

• 4.1. Technology Movement Analysis & Market Share, 2025 & 2033
• 4.2. Market Size & Forecasts and Trend Analysis, by Technology, 2021 to 2033 (USD Million)
• 4.3. Mobile & Interim Imaging Services
  • 4.3.1. Mobile & Interim Imaging Services Market Estimates & Forecasts 2021 to 2033 (USD Million)
  • 4.3.2. Magnetic Resonance Imaging (MRI)
    • 4.3.2.1. Market Estimates & Forecasts 2021 to 2033 (USD Million)
  • 4.3.3. Positron Emission Tomography/Computed Tomography (PET/CT)
    • 4.3.3.1. Market Estimates & Forecasts 2021 to 2033 (USD Million)
  • 4.3.4. Catheterization & Angiography (Cath/Angio)
    • 4.3.4.1. Market Estimates & Forecasts 2021 to 2033 (USD Million)
  • 4.3.5. Nuclear Medicine
    • 4.3.5.1. Market Estimates & Forecasts 2021 to 2033 (USD Million)
  • 4.3.6. Bone Density (DEXA Scan)
    • 4.3.6.1. Market Estimates & Forecasts 2021 to 2033 (USD Million)
  • 4.3.7. Ultrasound
    • 4.3.7.1. Market Estimates & Forecasts 2021 to 2033 (USD Million)
  • 4.3.8. Mammography (2D & 3D)
    • 4.3.8.1. Market Estimates & Forecasts 2021 to 2033 (USD Million)
• 4.4. Fixed Radiology Services
  • 4.4.1. Fixed Radiology Services Market Estimates & Forecasts 2021 to 2033 (USD Million)
  • 4.4.2. Magnetic Resonance Imaging (MRI)
    • 4.4.2.1. Market Estimates & Forecasts 2021 to 2033 (USD Million)
  • 4.4.3. Computed Tomography (CT)
    • 4.4.3.1. Market Estimates & Forecasts 2021 to 2033 (USD Million)
  • 4.4.4. X-ray
    • 4.4.4.1. Market Estimates & Forecasts 2021 to 2033 (USD Million)
  • 4.4.5. Mammography
    • 4.4.5.1. Market Estimates & Forecasts 2021 to 2033 (USD Million)
  • 4.4.6. Ultrasound
    • 4.4.6.1. Market Estimates & Forecasts 2021 to 2033 (USD Million)
  • 4.4.7. Nuclear Imaging
    • 4.4.7.1. Market Estimates & Forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. Imaging Services Market: Application Estimates & Trend Analysis

• 5.1. Application Movement Analysis & Market Share, 2025 & 2033
• 5.2. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.3. Orthopedics
  • 5.3.1. Orthopedics Market Estimates & Forecasts, 2021 - 2033 (USD Million)
• 5.4. Gynecology
  • 5.4.1. Gynecology Market Estimates & Forecasts, 2021 - 2033 (USD Million)
• 5.5. Oncology
  • 5.5.1. Oncology Market Estimates & Forecasts, 2021 - 2033 (USD Million)
• 5.6. Cardiology
  • 5.6.1. Cardiology Market Estimates & Forecasts, 2021 - 2033 (USD Million)
• 5.7. Gastroenterology
  • 5.7.1. Gastroenterology Market Estimates & Forecasts, 2021 - 2033 (USD Million)
• 5.8. Neurology
  • 5.8.1. Neurology Market Estimates & Forecasts, 2021 - 2033 (USD Million)
• 5.9. Other Applications
  • 5.9.1. Other Applications Market Estimates & Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Imaging Services Market: End Use Estimates & Trend Analysis

• 6.1. End Use Market Share, 2025 & 2033
• 6.2. End Use Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
• 6.5. Diagnostic Imaging Centers
  • 6.5.1. Diagnostic Imaging Centers Market Estimates & Forecasts, 2021 - 2033 (USD Million)
• 6.6. Mobile Imaging Providers
  • 6.6.1. Mobile Imaging Providers Market Estimates & Forecasts, 2021 - 2033 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market Estimates & Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Participant Overview
• 7.2. Company Market Position Analysis
• 7.3. Company Categorization
• 7.4. Strategy Mapping
• 7.5. Company Profiles/Listing
  • 7.5.1. Radnet, Inc.
    • 7.5.1.1. Company Overview
    • 7.5.1.2. Financial Performance
    • 7.5.1.3. Product Benchmarking
    • 7.5.1.4. Strategic Initiatives
  • 7.5.2. Alliance Medical
    • 7.5.2.1. Company Overview
    • 7.5.2.2. Financial Performance
    • 7.5.2.3. Product Benchmarking
    • 7.5.2.4. Strategic Initiatives
  • 7.5.3. Inhealth Group
    • 7.5.3.1. Company Overview
    • 7.5.3.2. Financial Performance
    • 7.5.3.3. Product Benchmarking
    • 7.5.3.4. Strategic Initiatives
  • 7.5.4. Sonic Healthcare
    • 7.5.4.1. Company Overview
    • 7.5.4.2. Financial Performance
    • 7.5.4.3. Product Benchmarking
    • 7.5.4.4. Strategic Initiatives
  • 7.5.5. Dignity Health
    • 7.5.5.1. Company Overview
    • 7.5.5.2. Financial Performance
    • 7.5.5.3. Product Benchmarking
    • 7.5.5.4. Strategic Initiatives
  • 7.5.6. Medica Group
    • 7.5.6.1. Company Overview
    • 7.5.6.2. Financial Performance
    • 7.5.6.3. Product Benchmarking
    • 7.5.6.4. Strategic Initiatives
  • 7.5.7. Global Diagnostics
    • 7.5.7.1. Company Overview
    • 7.5.7.2. Financial Performance
    • 7.5.7.3. Product Benchmarking
    • 7.5.7.4. Strategic Initiatives
  • 7.5.8. Novant Health
    • 7.5.8.1. Company Overview
    • 7.5.8.2. Financial Performance
    • 7.5.8.3. Product Benchmarking
    • 7.5.8.4. Strategic Initiatives
  • 7.5.9. Concord Medical Services Holdings Limited
    • 7.5.9.1. Company Overview
    • 7.5.9.2. Financial Performance
    • 7.5.9.3. Product Benchmarking
    • 7.5.9.4. Strategic Initiatives
  • 7.5.10. Center for Diagnostic Imaging, Inc.
    • 7.5.10.1. Company Overview
    • 7.5.10.2. Financial Performance
    • 7.5.10.3. Product Benchmarking
    • 7.5.10.4. Strategic Initiatives
  • 7.5.11. Unilabs
    • 7.5.11.1. Company Overview
    • 7.5.11.2. Financial Performance
    • 7.5.11.3. Product Benchmarking
    • 7.5.11.4. Strategic Initiatives
  • 7.5.12. Healius Limited
    • 7.5.12.1. Company Overview
    • 7.5.12.2. Financial Performance
    • 7.5.12.3. Product Benchmarking
    • 7.5.12.4. Strategic Initiatives
  • 7.5.13. Simonmed Imaging
    • 7.5.13.1. Company Overview
    • 7.5.13.2. Financial Performance
    • 7.5.13.3. Product Benchmarking
    • 7.5.13.4. Strategic Initiatives